Dr. Bien-Gund is a double board-certified physician in Internal Medicine and Infectious Diseases. He is an Assistant Professor in the Division of Infectious Diseases at the University of Pennsylvania. His research has focused on various points of the HIV care cascade, including expanded HIV/STI testing services for men who have sex with men (MSM), pre-exposure prophylaxis (PrEP) uptake, and strategies to increase ART adherence. In addition, prior research has focused on the role of ART and viral suppression on nicotine metabolism in people living with HIV.
Current research projects focus on investigating linkage to care after HIV self-testing, the prevention care continuum, and implementation of pharmacy-based HIV testing and PrEP. Dr. Bien-Gund has conducted research examining self-testing strategies and secondary distribution. In response to the COVID-19 pandemic, he oversaw a clinical trial that investigates the secondary distribution of COVID-19 self-tests to underserved populations in the Philadelphia metropolitan area. As part of his MSCE thesis, he investigated use of self-testing uptake among over 6,000 MSM in the United States.
